A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato,[...]. Nat Commun 2020
50
75

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
316
50

Mitochondrial control of innate immune signaling by irradiated cancer cells.
Takahiro Yamazaki, Lorenzo Galluzzi. Oncoimmunology 2020
17
50


Type I interferons and endoplasmic reticulum stress in health and disease.
Jenny Sprooten, Abhishek D Garg. Int Rev Cell Mol Biol 2020
35
50

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, John M Abrams, Dieter Adam, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, Ivano Amelio, David W Andrews,[...]. Cell Death Differ 2018
50

Immunomodulation by anticancer cell cycle inhibitors.
Giulia Petroni, Silvia C Formenti, Selina Chen-Kiang, Lorenzo Galluzzi. Nat Rev Immunol 2020
56
50

PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models.
Takahiro Yamazaki, Aitziber Buqué, Tyler D Ames, Lorenzo Galluzzi. Oncoimmunology 2020
42
50

Immunomodulation by targeted anticancer agents.
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Cancer Cell 2021
68
50

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.
Maria Esperanza Rodriguez-Ruiz, Ilio Vitale, Kevin J Harrington, Ignacio Melero, Lorenzo Galluzzi. Nat Immunol 2020
121
50

Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buqué, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro Manzano,[...]. Nat Immunol 2020
124
50

The hallmarks of successful anticancer immunotherapy.
Lorenzo Galluzzi, Timothy A Chan, Guido Kroemer, Jedd D Wolchok, Alejandro López-Soto. Sci Transl Med 2018
288
50

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.
Heng Yang, Lin Xia, Jian Chen, Shuqing Zhang, Vincent Martin, Qingqing Li, Shangqing Lin, Jinfeng Chen, Joseph Calmette, Min Lu,[...]. Nat Med 2019
102
50

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Maria Paula Roberti, Satoru Yonekura, Connie P M Duong, Marion Picard, Gladys Ferrere, Maryam Tidjani Alou, Conrad Rauber, Valerio Iebba, Christian H K Lehmann, Lukas Amon,[...]. Nat Med 2020
68
50

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Filippo Veglia, Emilio Sanseviero, Dmitry I Gabrilovich. Nat Rev Immunol 2021
266
50

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Allan Sauvat, Pamela Caudana, Jimena Tosello Boari, Norma Bloy, Sylvie Lachkar,[...]. J Exp Med 2021
6
50

Hallmarks of Health.
Carlos López-Otín, Guido Kroemer. Cell 2021
123
50

Beneficial autoimmunity improves cancer prognosis.
Laurence Zitvogel, Claude Perreault, Olivera J Finn, Guido Kroemer. Nat Rev Clin Oncol 2021
33
50

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment.
Min Yang, Wenwen Du, Lixian Yi, Shaoxian Wu, Chunyan He, Wensi Zhai, Cuihua Yue, Runzi Sun, Ashley V Menk, Greg M Delgoffe,[...]. Oncoimmunology 2020
18
25

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.
Rianne D W Vaes, Lizza E L Hendriks, Marc Vooijs, Dirk De Ruysscher. Cells 2021
18
25

Immunological role of TAM receptors in the cancer microenvironment.
Varsha Gadiyar, Gopi Patel, Viralkumar Davra. Int Rev Cell Mol Biol 2020
5
25

Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides.
Ilio Vitale, Takahiro Yamazaki, Erik Wennerberg, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria, Lorenzo Galluzzi. Trends Cancer 2021
12
25

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.
Abhishek D Garg, Lien Vandenberk, Shentong Fang, Tekele Fasche, Sofie Van Eygen, Jan Maes, Matthias Van Woensel, Carolien Koks, Niels Vanthillo, Norbert Graf,[...]. Cell Death Differ 2017
71
25


Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.
Els Wauters, Pierre Van Mol, Abhishek Dinkarnath Garg, Sander Jansen, Yannick Van Herck, Lore Vanderbeke, Ayse Bassez, Bram Boeckx, Bert Malengier-Devlies, Anna Timmerman,[...]. Cell Res 2021
117
25

Programmed cell death and the immune system.
Shigekazu Nagata, Masato Tanaka. Nat Rev Immunol 2017
221
25

The role of dendritic cells in cancer.
Yoke Seng Lee, Kristen J Radford. Int Rev Cell Mol Biol 2019
50
25

Immunotherapy biomarkers: the long and winding road.
Tyler J Alban, Timothy A Chan. Nat Rev Clin Oncol 2021
4
25


Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.
Alessandra Rossi, Valeria Lucarini, Iole Macchia, Paola Sestili, Carla Buccione, Simona Donati, Maria Ciccolella, Antonella Sistigu, Maria Teresa D'Urso, Anna Maria Pacca,[...]. Cells 2020
6
25

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
Tal Flieswasser, Jinthe Van Loenhout, Laurie Freire Boullosa, Astrid Van den Eynde, Jorrit De Waele, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, Patrick Pauwels, Julie Jacobs. Cells 2020
18
25

Cell death pathologies: targeting death pathways and the immune system for cancer therapy.
Francesca Pentimalli, Sandro Grelli, Nicola Di Daniele, Gerry Melino, Ivano Amelio. Genes Immun 2019
25
25

Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.
Hector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, Isabel García, Marco Marradi, Javier Freire, Erwan Salmon, Mar Portillo-Gonzalez, Elisabet Frande-Cabanes, Almudena García-Castaño,[...]. Oncoimmunology 2018
12
25

Redox regulation of immunometabolism.
Jonathan Muri, Manfred Kopf. Nat Rev Immunol 2021
103
25

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity.
Terry Medler, Jaina M Patel, Alejandro Alice, Jason R Baird, Hong-Ming Hu, Michael J Gough. Int Rev Cell Mol Biol 2019
24
25

Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors.
Yu Zhang, Xin-Yuan Guan, Peng Jiang. Front Immunol 2020
29
25

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer.
Stephane Paul, Etienne Regulier, Yves Poitevin, Horst Hormann, R Bruce Acres. Cancer Immunol Immunother 2002
14
25


A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo.
Mathias Vormehr, Katharina Reinhard, Renata Blatnik, Kathrin Josef, Jan David Beck, Nadja Salomon, Martin Suchan, Abderraouf Selmi, Fulvia Vascotto, Johannes Zerweck,[...]. Oncoimmunology 2018
10
25


Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.
Jing Liu, Elisa A Rozeman, Jake S O'Donnell, Stacey Allen, Lorenzo Fanchi, Mark J Smyth, Christian U Blank, Michele W L Teng. Oncoimmunology 2018
24
25

Multiverse of immune microenvironment in metastatic colorectal cancer.
Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, Jérôme Galon. Oncoimmunology 2020
8
25

Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy.
Jian-Guo Zhou, Bo Liang, Jian-Guo Liu, Su-Han Jin, Si-Si He, Benjamin Frey, Ning Gu, Rainer Fietkau, Markus Hecht, Hu Ma,[...]. Cells 2021
11
25

Necroptotic signaling in adaptive and innate immunity.
Jennifer V Lu, Helen C Chen, Craig M Walsh. Semin Cell Dev Biol 2014
37
25

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome.
Jing Liu, Jake S O'Donnell, Juming Yan, Jason Madore, Stacey Allen, Mark J Smyth, Michele W L Teng. Oncoimmunology 2019
45
25

The clinical role of the TME in solid cancer.
Nicolas A Giraldo, Rafael Sanchez-Salas, J David Peske, Yann Vano, Etienne Becht, Florent Petitprez, Pierre Validire, Alexandre Ingels, Xavier Cathelineau, Wolf Herman Fridman,[...]. Br J Cancer 2019
190
25

Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies.
Yunbin Zhang, Jiang Xu, Ning Zhang, Ming Chen, Hua Wang, Di Zhu. Cancer Lett 2019
25
25


First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
François Anna, Elodie Bole-Richard, Joel LeMaoult, Marie Escande, Martin Lecomte, Jean-Marie Certoux, Philippe Souque, Francine Garnache, Olivier Adotevi, Pierre Langlade-Demoyen,[...]. J Immunother Cancer 2021
14
25

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling.
Camilla Heiniö, Riikka Havunen, Joao Santos, Klaas de Lint, Victor Cervera-Carrascon, Anna Kanerva, Akseli Hemminki. Cells 2020
17
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.